Bank Of New York Mellon Corp Pro Phase Labs, Inc. Transaction History

Bank Of New York Mellon Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$8.78 - $12.47 $576,380 - $818,618	65,647 New	65,647 $632,000
Q2 2022 Aug 15, 2022	SELL	$6.52 - $13.24 $541 - $1,098	-83 Reduced 0.19%	42,711 $542,000
Q1 2022 May 11, 2022	SELL	$6.2 - $7.87 $38,477 - $48,841	-6,206 Reduced 12.67%	42,794 $300,000
Q3 2021 Nov 12, 2021	SELL	$4.89 - $7.82 $205,820 - $329,143	-42,090 Reduced 46.21%	49,000 $254,000
Q1 2021 May 13, 2021	BUY	$6.19 - $16.0 $413,628 - $1.07 Million	66,822 Added 275.35%	91,090 $674,000
Q4 2020 Feb 09, 2021	SELL	$3.9 - $11.25 $358,885 - $1.04 Million	-92,022 Reduced 79.13%	24,268 $222,000
Q1 2020 May 06, 2020	BUY	$1.74 - $2.1 $1 - $2	1 Added 0.0%	116,290 $219,000
Q2 2019 Aug 12, 2019	SELL	$2.1 - $3.07 $3,792 - $5,544	-1,806 Reduced 1.53%	116,289 $250,000
Q1 2019 May 14, 2019	SELL	$2.7 - $3.65 $159 - $215	-59 Reduced 0.05%	118,095 $355,000
Q4 2017 Feb 09, 2018	BUY	$2.05 - $2.3 $242,215 - $271,754	118,154	118,154 $256,000

1.71M

Ticker PRPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 16,024,400
Market Cap $10.1M
Description
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.